Publication date: Jan 16, 2019 The overall survival (OS) of patients with metastatic uveal melanoma is short, the evidence for effectiveness of treatments is limited, and no consensus on the ... Read more

Publication date: Feb 01, 2019 Robinson, J.K., Reavy, R., Mallett, K.A., and Turrisi, R. Remote partner assisted skin self-examination skills training of melanoma survivors and their partners. 21699. 2019 Australas ... Read more

Publication date: Feb 15, 2019 In melanoma, initiating oncogenic mutations in BRAF or NRAS are detected in premalignant lesions that accumulate additional mutations and genomic instability as the tumour evolves ... Read more

Publication date: Feb 15, 2019 Schadendorf, D., Livingstone, E., and Zimmer, L. Treatment in metastatic melanoma – Time to re-think. 21696. 2019 Ann Oncol.

Read more

Publication date: Feb 15, 2019 The aim of this study was to investigate the presence of intraocular lymphatic vessels in patients with uveal melanomas and extrascleral extension using a panel ... Read more

Publication date: Feb 20, 2019 Recent studies indicated that the autoimmunity of vitiligo exerts effects on cells other than melanocytes, which confer reduced risks of both melanoma and nonmelanoma skin ... Read more

Publication date: Feb 19, 2019 Resistance to checkpoint-blockade treatments is a challenge in the clinic. We found that although treatment with combined anti-CTLA-4 and anti-PD-1 improved control of established tumors, ... Read more

Publication date: Feb 19, 2019 We used four-color ImmunoSpot(R) assays, in conjunction with peptide pools that cover the sequence of tyrosinase (Tyr), melanoma-associated antigen A3 (MAGE-A3), melanocyte antigen/melanoma antigen recognized ... Read more

Publication date: Feb 19, 2019 Acquired resistance to BRAF kinase inhibitors (BRAFi) is the primary cause for their limited clinical benefit. Although several mechanisms of acquired BRAFi resistance have been ... Read more

Publication date: Feb 19, 2019 We have previously developed the caspase-based radiotracer, F-ICMT-11, for PET imaging to monitor treatment response. We further validated F-ICMT-11 specificity in a murine melanoma death-switch ... Read more